|
|
|
Volumn 52, Issue 1344, 2010, Pages 63-64
|
|
Aztreonam for inhalation solution (Cayston) for cystic fibrosis.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZTREONAM;
ANIMAL;
CYSTIC FIBROSIS;
DRUG EFFECT;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
METHODOLOGY;
MICROBIOLOGY;
PHASE 3 CLINICAL TRIAL;
PSEUDOMONAS AERUGINOSA;
REVIEW;
SOLUTION AND SOLUBILITY;
ADMINISTRATION, INHALATION;
ANIMALS;
AZTREONAM;
CLINICAL TRIALS, PHASE III AS TOPIC;
CYSTIC FIBROSIS;
HUMANS;
PHARMACEUTICAL SOLUTIONS;
PSEUDOMONAS AERUGINOSA;
|
|
EID: 77956017415
PISSN: None
EISSN: 15232859
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (5)
|